Melatonin improves metabolic syndrome induced by high fructose intake in rats

Journal of Pineal Research

Volumn 52, Issue 4, 2012, Pages 403-413

  Kitagawa, Akira ^a   Ohta, Yoshiji ^b   Ohashi, Koji ^c  

^a Chukyo Women's University   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

dyslipidemia; High fructose feeding (rat); hyperuricemia; insulin resistance; melatonin; metabolic syndrome; oxidative stress

Indexed keywords

ADIPONECTIN; CHOLESTEROL; FATTY ACID; FRUCTOSE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPID PEROXIDE; MELATONIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; CONTROLLED STUDY; DRUG MEGADOSE; FATTY ACID BLOOD LEVEL; FEEDING; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; INTRAABDOMINAL FAT; LIVER WEIGHT; LOW DRUG DOSE; MALE; METABOLIC SYNDROME X; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; RAT; SUGAR INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADIPOKINES; ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL; DIET; FRUCTOSE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; LIPID PEROXIDES; LIPIDS; LIVER; MALE; MELATONIN; METABOLIC SYNDROME X; OXIDATIVE STRESS; RATS; RATS, WISTAR; URIC ACID;

EID: 84859710610     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2011.00955.x     Document Type: Article

References (57)

1. Kassai E, Prevanidou P, Kaltas G, Chrousos G,. Metabolic syndrome: definitions and controversies. BMC Med 2011; 9: 48.
2. Roberts CK, Sindhu KK,. Oxidative stress and metabolic syndrome. Life Sci 2009; 84: 705-712.
3. Elks CM, Francis J,. Central adiposity, systemic inflammation, and the metabolic syndrome. Curr Hypertens Rep 2010; 12: 99-104.
4. Stanhope KL, Havel PJ,. Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am J Clin Nutr 2008; 88 (Suppl): 1733S-1737S.
5. Swarbrick MM, Stanhope KL, Elliot SS, et al., Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br J Nutr 2008; 100: 947-952.
6. Teff KL, Grudziak G, Townsend RR, et al., Endocrine and metabolic effect of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J Clin Endocrinol Metab 2009; 94: 1562-1569.
7. Perez-Pozo SE, Schold J, Nakagawa T, Sánchez-Lozada LG, Johnson RJ, Lillo JL,. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int J Obes 2010; 34: 454-461.
8. Stanhope KL, Havel P,. Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans. J Nutr 2009; 139: 1236S-1241S.
9. Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K,. Fructose; a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010; 299: E685-E694.
10. Miller A, Adeli K,. Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 2008; 24: 204-209.
11. Tran LT, Yuen VG, McNeill JH,. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem 2009; 332: 145-159.
12. Reiter RJ, Tan D-X, Fuentes-Broto L,. Melatonin: a multitasking molecule. Prog Brain Res 2010; 181: 127-151.
13. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ,. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200.
14. Bonnefront-Rousselot D, Colin D, Jore D, Gardès-Albert M,. Reaction mechanism of melatonin oxidation by reactive oxygen. J Pineal Res 2011; 50: 328-335.
15. Galano A, Tan DX, Reitter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-6.
16. Radogna F, Diedreich M, Chilbelli L,. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 2010; 80: 1844-852.
17. Korkmaz A, Topal T, Tan D-X, Reiter RJ,. Role of melatonin in metabolic regulation. Rev Endocr Metab Disord 2009; 10: 261-270.
18. Simko F, Paulis L,. Melatonin as a potential antihypertensive treatment. J Pineal Res 2007; 42: 319-322.
19. Robera R, Kirilov G, Tomova A, Jumanov P,. Melatonin-insulin interactions in patients with metabolic syndrome. J Pineal Res 2008; 44: 52-56.
20. Koziroacute;g MK, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M,. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res 2011; 50: 261-266.
21. Prunet-Marcassus B, Desbazeille M, Bros A, et al., Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology 2003; 144: 5347-4352.
22. Pan M, Song Y-L, Xu J-M, Gan H-Z,. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet. J Pineal Res 2006; 41: 79-84.
23. Ríos-Lugo MJ, Cano P, Jimenez-Mateos MP, et al., Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high-fat fed rats. J Pineal Res 2010; 49: 432-348.
24. Zaitone S, Hassan N, El-Orabi N, El-Awady E-S,. Pentoxiflylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease. Eur J Pharmacol 2011; 62: 70-77.
25. Agli A, Navarro-Alarcón M, Ruiz R, et al., Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats. J Pineal Res 2010; 50: 207-212.
26. Tan D-X, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ,. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev 2011; 12: 167-188.
27. She M, Deng X, Cuo Z, et al., NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose- fed rats. Pharmacol Res 2009; 59: 248-253.
28. Leibowitz A, Peleg E, Sharabi Y, Shabtai Z, Shamiss A, Grossman E,. The role of melatonin in the pathogenesis of hypertension in rats with metabolic syndrome. Am J Hypertens 2008; 21: 348-351.
29. Matthewa DR, Hisker JP, Rudenski AS,. Homeostasis model assessment: insulin and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
30. Katz A, Nambi SS, Mather K, et al., Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocronol Metab 2000; 85: 2402-2410.
31. Yagi K,. A simple fluorometric assay for lipoperoxides in blood sample. Biochem Med 1975; 15: 212-216.
32. Ohkawa H, Ohishi N, Yagi K,. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
33. Sedlak J, Lindsay RH,. Estimation of total, protein-bound, and non-protein sulfhydryl groups in animal tissues with Ellman's reagent. Anal Biochem 1968; 25: 192-205.
34. Sardesai VM, Manning JA,. The determination of triglycerides in plasma and tissues. Clin Chem 1968; 14: 156-161.
35. Ziatkis A, Zak B,. Study of a new cholesterol reagent. Anal Biochem 1969; 29: 143-148.
36. Kawasaki T, Igarashi K, Koeda T, et al., Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 2009; 139: 2067-071.
37. Borges RL, Ribeiro AB, Zanella MT, Batista MC,. Uric acid as a factor in the metabolic syndrome. Curr Hypertens Rep 2010; 2: 113-119.
38. Angelopoulos TJ, Lowndes J, Zukley L, et al., The effect of high-fructose corn syrup consumption on triglycerides and uric acid. J Nutr 2009; 139: 1242S-1245S.
39. Nakagawa T, Hu H, Zharikov S, et al., A causal role of uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625-F631.
40. Hu Q-H, Wang C, Li J-M, Kong L-D,. Allopurinol, rutin, ad quercetin attenuate hyperurricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. Am J Physiol Renal Physiol 2009; 297: F1080-F1091.
41. Maury E, Brichard SM,. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010; 314: 1-16.
42. Soodini GR, Hamdy O,. Adiponectin sand leptin in relation to insulin sensitivity. Metab Syndr Relat Disord 2004; 2: 114-123.
43. Ruan H, Lodish HF,. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α. Cytokines Growth Factor Rev 2003; 14: 447-455.
44. Alzamendi A, Giovambattisa A, Raschia A, et al., Fructose-rich diet-induced abdominal adipose tissue endocrine dysfunction in normal male rats. Endocrine 2000; 25: 227-232.
45. Kamari Y, Grossman E, Oron-Herman M, Shabtay PZ, Shamiss A, Sharabi Y,. Metabolic stress with a high carbohydrate diet increases adiponectin levels. Horm Metab Res 2007; 39: 384-388.
46. Qin B, Polansky MM, Anderson RA,. Cinnamon extract regulates plasma levels of adipose-derived factors and expression of multiple genes related to carbohydrate metabolism and lipogenesis in adipose tissue of fructose-fed rats. Horm Metab Res 2010; 42: 187-191.
47. Sharabi Y, Oron-Herman M, Kamari Y, et al., Effect of PPAR-γ agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model. Am J Hypertens 2007; 20: 206-210.
48. El-Bassossy HM, El-Moselly MA, Mahmound ME,. Pentoxiflline alleviates vascular impairment in insulin resistance via TNF-α inhibition. Naunyn Schmiedebergs Arch Pharmacol 2011; 384: 277-285.
49. Roglans N, Vilà L, Farré M, et al., Impairment of hepatic Stat-3 activation and reduction of PPARa activity in fructose-fed rats. Hepatology 2007; 45: 778-788.
50. Behr-Roussel D, Oudot A, Caisey S, et al., Daily treatment with sildenafil reverses endothelial dysfunction and oxidative stress in an animal model of insulin resistance. Eur Urol 2008; 53: 1272-1281.
51. Canpolat S, Sandel S, Yilmaz B, et al., Effects of pinealectomy and exogenous melatonin on serum leptin levels in male rat. Eur J Pharmacol 2001; 428: 145-148.
52. Silbernagel G, Machann J, Unmuth S, et al., Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr 2011; 106: 79-86.
53. Baydas G, Yilmaz O, Celik S, Yasar A, Gursu MF,. Effects of certain micronutrients and melatonin on plasma lipid, lipid peroxidation, and homocysteine levels in rats. Arch Med Res 2002; 33: 515-519.
54. Chan TY, Tang PL,. Effect of melatonin on the maintenance of cholesterol homeostasis in the rat. Endocrinol Res 1995; 21: 681-696.
55. Miller-Wieland D, Behnke B, Koopmann K, Krone W,. Melatonin inhibits LDL receptor activity and cholesterol synthesis in fleshly isolated human mononuclear leukocytes. Biochem Biophys Res Commun 1994; 202: 416-421.
56. Brydon L, Petit L, Delagrance P, Strosberg D, Jockers R,. Functional expression of MT2 (Met 1b) melatonin receptors in human PAZ 6 adipocytes. Endocrinology 2001; 142: 4264-4271.
57. Alonso-Vale MIC, Andreotti S, Eres SB, et al., Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab 2005; 288: 805-812.